GlassScriptPhysician profile
Sandy K Nguy
NPI 1124473467
$4,217.87
in general payments reported to CMS, 2019-2025
50 companies · $74.96 in 2025
The $74.96 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $191 · 2020: $263 · 2021: $719 · 2022: $1,284 · 2023: $1,549 · 2024: $137 · 2025: $74.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,761.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,760.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $477.42 | 2019-2024 | |
| Glaxosmithkline, LLC. | $405.17 | 2019-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Novo Nordisk INC | $365.30 | 2021-2023 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $265.88 | 2021-2023 | Jardiance, Mounjaro, Emgality |
| Astrazeneca Pharmaceuticals LP | $265.43 | 2019-2023 | Farxiga |
| Merck Sharp & Dohme LLC | $204.36 | 2019-2023 | Belsomra, Steglatro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $180.56 | 2019-2023 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $149.34 | 2022-2023 | |
| Corium, LLC | $147.68 | 2022-2023 | Azstarys |
| Itamar Medical INC | $134.51 | 2022-2023 | Watchpatone |
| Biohaven Pharmaceutical Holding Company LTD. | $129.23 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $113.36 | 2020-2021 | |
| Pfizer INC. | $110.87 | 2022-2025 | |
| Idorsia Pharmaceuticals US INC | $106.34 | 2023 | Quviviq |
| Esperion Therapeutics, INC. | $94.29 | 2020-2021 |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandy Nguy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.